SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-176579
Filing Date
2024-07-09
Accepted
2024-07-09 08:00:33
Documents
15
Period of Report
2024-07-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d855324d8k.htm   iXBRL 8-K 30041
2 EX-3.1 d855324dex31.htm EX-3.1 5211
  Complete submission text file 0001193125-24-176579.txt   201065

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xoma-20240708.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20240708_def.xml EX-101.DEF 14184
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20240708_lab.xml EX-101.LAB 23923
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20240708_pre.xml EX-101.PRE 15076
17 EXTRACTED XBRL INSTANCE DOCUMENT d855324d8k_htm.xml XML 7198
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 241106361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)